Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-11-21Clinical Trial Update: Study of Use of CTC in NSCLC
A clinical trial update from the University of Virginia regarding the use of circulating tumor cells (CTCs) in Non-Small Cell Lung Cancer, w…
-
CLINICAL_TRIALS research · 2013-11-14Clinical Trial Update: Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC) [Phase 1, Phase 2]
This clinical trial update concerns a Phase 1/2 study evaluating the combination of vorinostat and gefitinib in relapsed or refractory advan…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression [Phase 3]
A Phase 3 trial evaluating the combination of gossypol with docetaxel and cisplatin in advanced non-small cell lung cancer with high APE1 ex…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer [Phase 2]
This document reports a Phase 2 clinical trial update of a biological therapy in patients with non-small cell lung cancer who have previousl…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]
The document reports an Epimmune-sponsored Phase 2 trial of a vaccine therapy for stage IIIB, stage IV, or recurrent non-small cell lung can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-10-28Clinical Trial Update: Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m
This clinical trial update provides an epidemiological and scientific evaluation of EGFR mutation status in patients with newly diagnosed lo…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2, Phase 3]
Clinical trial update on gemcitabine plus supportive care for locally advanced or metastatic non-small cell lung cancer, covering Phase 2 an…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy
This clinical trial update describes a study evaluating biomarkers to predict treatment response in samples from patients with early-stage n…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer [Phase 1]
This document describes a Phase 1 clinical trial evaluating phosphorus-32 in combination with radiation therapy and chemotherapy for patient…
-
CLINICAL_TRIALS research · 2013-08-30Clinical Trial Update: An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib [Phase 2]
Open-label Phase 2 study of Afatinib (BIBW 2992) in advanced non-small cell lung cancer patients previously treated with Erlotinib or Gefiti…
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 study evaluating gemcitabine in combination with either cisplatin or carboplatin in patients with stage III or stage IV non-small …
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer [NA]
An update on a clinical trial evaluating the use of PET/CT imaging prior to surgical treatment in patients across five cancer types.
-
CLINICAL_TRIALS research · 2013-08-13Clinical Trial Update: Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC
A clinical trial update comparing presentation and treatment response between never-smokers and smokers with non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer [Phase 2]
This entry describes a Phase 2 clinical trial evaluating gemcitabine and cisplatin given before or after surgery in patients with stage I or…
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial assessing whether blood and tissue biomarkers can predict response to second-line therapy with erlotinib hydrochloride or chem…
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating Paclitaxel and Carboplatin with or without nitroglycerin for previously untreated stage III or stag…
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 3]
This document provides a Phase 3 trial update on combination chemotherapy for stage IIIB or stage IV non-small cell lung cancer; the current…
-
CLINICAL_TRIALS research · 2013-08-02Clinical Trial Update: Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating whether preventive brain radiation therapy reduces brain metastases compared with observation in patients with ad…
-
CLINICAL_TRIALS research · 2013-07-18Clinical Trial Update: Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy
This clinical trial update describes a study combining preconditioning chemotherapy with cytokine-induced killer (CIK) cell immunotherapy fo…
-
CLINICAL_TRIALS research · 2013-07-08Clinical Trial Update: A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers [NA]
This document provides a clinical trial update on sequential pemetrexed maintenance therapy for non-small cell lung cancer and discusses rel…
-
CLINICAL_TRIALS research · 2013-07-03Clinical Trial Update: VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer
Clinical trial update suggests VEGF receptor status may predict benefit from bevacizumab in advanced non-small cell lung cancer, including p…
-
CLINICAL_TRIALS research · 2013-06-07Clinical Trial Update: Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung [Phase 2]
Phase II neoadjuvant trial comparing nab-paclitaxel/carboplatin with paclitaxel/carboplatin in stage IIb and IIIA squamous cell carcinoma of…
-
CLINICAL_TRIALS research · 2013-05-23Clinical Trial Update: Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer [Phase 2]
Phase II study evaluating dovitinib for FGFR1-amplified squamous non-small cell lung cancer; the current status is unknown.
-
CLINICAL_TRIALS research · 2013-05-09Clinical Trial Update: Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen [Phase 2]
This Clinical Trials update describes a Phase 2 study evaluating sequential low-dose sunitinib with chemotherapy in patients with advanced n…
-
CLINICAL_TRIALS research · 2013-05-03Clinical Trial Update: Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC) [Phase 1]
This update describes a Phase 1 dose-defining study evaluating the AKT inhibitor MK-2206 in combination with gefitinib for non-small cell lu…